/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $154.3 billion, Boston Scientific Corporation (BSX) is a global developer, manufacturer, and marketer of medical devices used across a wide range of interventional medical specialties. With a diversified portfolio and a mix of organic growth and strategic acquisitions, the company operates through key segments including Cardiovascular, Rhythm and Neuro, and MedSurg.
The Marlborough, Massachusetts-based company is slated to announce its fiscal Q2 2025 earnings results before the market opens on Wednesday, Jul. 23. Ahead of the event, analysts expect BSX to report an adjusted EPS of $0.72, up 16.1% from $0.62 in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in the past four quarterly reports.